Related Experiment Video
Updated: Mar 12, 2026
12:28
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
7.8K
Targeting apoptotic pathways to treat lymphoid malignancies
1Department of Clinical Hematology and Bone Marrow Transplantation, The Royal Melbourne Hospital.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|November 1, 2016
Summary
Cancer cells often evade apoptosis, a programmed cell death process, through genetic mutations. Targeting BCL2 proteins shows promise for treating B cell cancers by restoring apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Cancer cells activate proliferation, leading to cellular stress that normally triggers apoptosis (programmed cell death).
- Hematological malignancies frequently possess genetic aberrations that enable cancer cells to evade apoptosis, with TP53 and BCL2 family mutations being common.
- The intrinsic pathway of apoptosis plays a crucial role in lymphoid cancers.
Purpose of the Study:
- To review the role of the intrinsic apoptosis pathway in lymphoid cancers.
- To discuss the regulation of apoptosis by BCL2 family proteins.
- To explore the therapeutic potential of BCL2 inhibition in B cell cancers.
Main Methods:
- Literature review and synthesis of current understanding.
- Focus on molecular mechanisms of apoptosis regulation.
- Analysis of emerging therapeutic strategies.
Main Results:
- Aberrations in apoptosis pathways, particularly involving TP53 and BCL2, are hallmarks of many hematological malignancies.
- BCL2 family proteins are key regulators of the intrinsic apoptosis pathway.
- Inhibiting BCL2 can re-sensitize cancer cells to apoptosis.
Conclusions:
- Understanding apoptosis regulation is critical for lymphoid cancer therapy.
- Targeting BCL2 offers a promising therapeutic strategy for BCL2-expressing B cell cancers.
- Restoring apoptosis in cancer cells is a viable approach to treatment.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
23.5K
08:12Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
10.1K
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
9.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:17The Extrinsic Apoptotic Pathway
9.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:17Phagocytosis of Apoptotic Cells
5.4K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
5.4K
01:27Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K